DeciBio Consulting's mission is to provide the market intel- ligence and strategic insights
that drive disruption and innovation
in the research tools, clinical diagnostics, and health technology markets.
“We appreciate the opportunities we
have to work with some of the most
innovative companies in the world
and drive disruptive technologies to
the market,” says Mika Wang, Director of Operations and Special Projects. “Inspired by our clients’ constant innovation, we remain committed to innovating our own consulting
methods, products, and services to
push the practice of consulting forward and to create increasing value
for the industry.” Wang sat down to
discuss the firm’s outstanding growth
the last three years.
Consulting: What were the
factors that contributed to
your firm’s growth?
Wang: Our growth is attributable
to hiring exceptional and passion-
ate people and empowering them
through an entrepreneurial envi-
ronment to develop novel content,
products, and insights for our cli-
ents. As a boutique firm, we can
focus on and quickly develop prod-
ucts in high-growth areas, such as
liquid biopsies, digital health, or
immuno-oncology. For example, in
response to our clients’ demand for
increasingly data-driven insights,
we have developed a unique hybrid
consulting-analytics offering that
combines traditional strategy con-
sulting layered on top of off-the-
shelf data analytics. The entrepre-
neurial nature of our firm allowed
a small team (myself and Data
Product Manager Pranay Madan) to
rapidly optimize this unique, hybrid
offering, which has contributed sig-
nificantly to our growth.
Consulting: How is this year
shaping up for your firm?
Wang: We expect above-market
growth in our consulting services
and triple-digit growth in our market
intelligence business. In the latter
business, we offer a variety of differentiated proprietary data products
as well as custom analyses.
Consulting: What's your firm’s
outlook for 2018?
Wang: In 2018, we see opportunities to provide strategic consulting
services to a broader base of clients in the research tools, clinical
diagnostics, and health technology
markets. We also see opportunities
for new compelling data products,
particularly in the areas of competitive intelligence, market analysis
(size/growth), and tactical sales
force targeting. Finally, we believe
there are opportunities to work
with the growing health technology sector here in Los Angeles.
Consulting: What's your firm’s
biggest challenges in 2018?
Wang: Our business is fueled by tal-
ented team members so our biggest
challenges for 2018 are to attract, de-
velop, and retain talented employees.
Consulting: What does being
named one of Consulting’s
Fastest Growing Firms mean
to your firm, your employees
and your clients?
Wang: We feel honored to be recognized by Consulting Magazine as
one of the Fastest Growing firms,
as it is a testament to our culture,
business model, and exceptional
team. We are unique in that we are
willing to deviate from tried-and-true formulas to develop innovative
processes, products, and solutions
for our clients. This often results in
output that breaks the mold of what
consulting or market research firms
typically produce, which we find
our clients appreciate.